Vasopressin and oxytocin receptors in the central nervous system

Critical Reviews in Neurobiology

Volumn 10, Issue 1, 1996, Pages 119-154

  Barberis, Claude ^a   Tribollet, Eliane ^b  

^a CCIPE   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Central distribution; Oxytocin receptor; Pharmacology; Plasticity; Primary sequences; Vasopressin receptor

Indexed keywords

BRAIN RECEPTOR; MOZAVAPTAN; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDE HORMONE ANTAGONIST; RELCOVAPTAN; STEROID HORMONE; VASOPRESSIN; VASOPRESSIN RECEPTOR;

AGE; ANIMAL CELL; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; DRUG POTENCY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOTHALAMUS; IN SITU HYBRIDIZATION; ISOTOPE LABELING; MESENCEPHALON; NERVE CELL PLASTICITY; NERVE LESION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; THALAMUS;

EID: 0029837656     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevneurobiol.v10.i1.60     Document Type: Review

References (287)

1. Jard, S., Elands, J., Schmidt, A., and Barberis, C., Vasopressin and oxytocin receptors: an overview, in Progress in Endocrinology, Imura, H. and Shizume, K., Eds., Elsevier, Amsterdam, 1988, 1183.
2. Barry, J., Recherches morphologiques et expérimentales sur la glande diencéphalique et l'appareil hypothalamo-hypophysaire, Annales Scientifiques de l'Université de Besançon, Zoologie et Physiologie, 2ème série, fasc. 15, 135, 1961.
3. Sofroniew, M. V., Vasopressin, oxytocin and their related neurophysins, in Handbook of Chemical Neuroanatomy, Björklund, A. and Hökfelt, T., Eds., Elsevier, Amsterdam, 4, 1985, 93.
4. Buijs, R. M., Vasopressin and oxytocin - their role in neurotransmission, Pharmacol. Ther., 22, 127, 1983.
5. Young, W. S. III., Expression of the oxytocin and vasopressin gene, J. Neuroendocrinol., 4, 528, 1993.
6. Voorn, P. and Buijs, R. M., An immunoelectromicroscopical study comparing vasopressin, oxytocin, substance P and enkephalin containing nerve terminals in the nucleus of the solitary tract of the rat, Brain Res., 270, 169, 1983.
7. Rousselot, P., Papadopoulos, G., Merighi, A., Poulain, D. A., and Theodosis, D. T., Oxytocinergic innervation of the rat spinal cord. An electron microscopic study, Brain Res., 529, 178, 1990.
8. Buijs, R. M. and Van Heerikhuize, J. J., Vasopressin and oxytocin release in the brain - a synaptic event., Brain Res., 252, 71, 1982.
9. Demotes-Mainard, J., Chauveau, J., Rodriguez, F., Vincent, J. D., and Poulain, D. A., Septal release of vasopressin in response to osmotic, hypovo-lemic and electrical stimulation in rats, Brain Res., 381, 314, 1986.
10. Landgraf, R., Neumann, L, and Schwarzberg, H., Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation, Brain Res., 457, 219, 1988.
11. Neumann, I. and Landgraf, R., Septal and hippocampal release of oxytocin, but not of vasopressin, in the conscious lactating rat during suckling, J. Neuroendocrinol., 1, 305, 1989.
12. Moos, F., Poulain, D. A., Rodriguez, F., Guerne, Y., Vincent, J. D., and Richard, P., Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats, Exp. Brain Res., 76, 593, 1989.
13. Kendrick, K. M., Keverne, E. B., Hinton, M. R., and Goode, J. A., Oxytocin, aminoacids and monoamine release in the region of the medial preoptic area and bed nucleus of the stria terminalis of the sheep during parturition and suckling, Brain Res., 569, 199, 1992.
14. Neumann, I., Russel, J. A., and Landgraf, R., Oxytocin and vasopressin release within the supraoptic and paraventricular nuclei of pregnant, parturient and lactating rats: a microdialysis study, Neurosci., 53, 65, 1993.
15. Landgraf, R., Malkinson, T. J., Horn, T., Veale, W. L., Lederis, K., and Pittman, Q. J., Release of vasopressin and oxytocin by paraventricular stimulation in rats, Am. J. Physiol., 259, R1056, 1990.
16. De Wied, D., Long-term maintenance effect of vasopressin on the maintenance of a conditioned avoidance response in rats, Nature, 232, 58, 1971.
17. Buijs, R. M., Vasopressin localization and putative functions in the brain, in Vasopressin: Principles and Properties, Gash D. M. and Boer G. J., Eds., Plenum Press, New York, 1987, 91.
18. De Kloet, E. R., Joëls, M., and Urban, I. J. A., Central neurohypophyseal hormone receptors and receptor mediated cellular responses, in Neuropeptides: Basics and Perspectives, De Wied D., Ed., Eisevier Science Publishers B.V., Amsterdam, 105, 1990.
19. Dantzer, R. and Bluthé, R. M., Vasopressin involvement in antipyresis, social communication and social recognition: a synthesis, Critical Reviews in Neurobiology, 16, 243, 1992.
20. Alescio-Lautier, B., Metzger, D., and Soumireu-Mourat, B., Central behavioral effects of vasopressin: point and perspectives, Rev. Neurosci., 4, 239, 1993.
21. De Wied, D., Diamant, M., and Fodor, M., Central nervous system effects of the neurohypophyseal hormones and related peptides, Frontiers in Neuroendocrinol., 14, 251, 1993.
22. Giri, P. R., Dave, J. R., Tabakoff, B., and Hoffman, P. L., Arginine vasopressin induces the expression of c-fos in the mouse septum and hippocampus, Mol. Brain Res., 7, 131, 1990.
23. Andreae, L. C. and Herbert, J., Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor, Neurosci., 53, 735, 1993.
24. Argiolas, A. and Gessa, G. L., Central functions of oxytocin, Neurosciences and Biobehavioral Rev., 15, 217, 1991.
25. Richard, P., Moos, F., and Freund-Mercier, M. J., Central effects of oxytocin, Physiol. Rev. 71, 331, 1991.
26. Insel, T. R., Oxytocin, a neuropeptide for affiliation: evidence from behavioral, receptor autoradiography and comparative studies, Psychoneuroendocrinol., 17, 3, 1992.
27. Flanagan, L. M., Pfaus, J. G., Pfaff, D. W., and McEwen, B. S., Induction of FOS immunoreactivity in oxytocin neurons after sexual activity in female rats, Neuroendocrinol., 58, 352, 1993.
28. Fenelon, V. S., Poulain, D. A., and Theodosis, D. T., Oxytocin neuron activation and fos expression: a quantitative immunocytochemical analysis of the effect of lactation, parturition, osmotic and cardiovascular stimulation, Neurosci., 53, 77, 1993.
29. Fenelon, V. S., Theodosis, D. T., and Poulain, D. A., Fos synthesis in identified magnocellular neurons varies with phenotype, stimulus, location in the hypothalamus and reproductive state, Brain Res., 662, 165, 1994.
30. Witt, D. M. and Insel, T. R., Increased Fos expression in oxytocin neurons following masculine sexual behavior, J. Neuroendocrinol., 6, 13, 1994.
31. 3H] vasopressin binding to rat hippocampal synaptic plasma membranes: kinetic and pharmacological characterization, FEBS Lett., 163, 400, 1983.
32. Audigier, S. and Barberis, C., Pharmacological characterization of two specific binding sites for neurohypophysial hormones in hippocampal synaptic membranes of the rat, EMBO J., 4, 1407, 1985.
33. Van Leeuwen, F. W., Vasopressin receptors in the brain and pituitary, in Vasopressin, Principles and Properties, Gash, D. M., and Boer, G. J., Eds., Plenum Press, New York, 1987, 477.
34. Tribollet, E., Vasopressin and oxytocin receptors in the rat brain, in Handbook of Chemical Neuroanatomy, Björklund, T., Hökfelt, T., and Kuhar, M. J., Eds., Elsevier, Amsterdam, 4, 1992, 289.
35. Fahrenholz, F., Boer, R., Crause, P., and Toth, M. V., Photoaffinity labeling of the renal V2 Vasopressin receptor. Identification and enrichment of a vasopressin-binding subunrt, Eur. J. Biochem., 152, 589, 1985.
36. Lutz, W., Sanders, M., Salisbury, J., and Kumar, R., Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors, Proc. Natl. Acad. Sci. U.S.A., 87, 6507, 1990.
37. Kojro, E., Hackenberg, M., Zsigo, J., and Fahrenholz, F., Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist, J. Biol. Chem., 266, 21416, 1991.
38. Lutz, W., Londowski, J. M., Sanders, M., Salisbury, J. L., and Kumar, R., A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors, J. Biol. Chem., 267, 1109, 1992.
39. Howl, J., Wang, X., Kirk, C. J., and Wheatley, M., Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor, FEBS Lett., 545, 1, 1992.
40. Thibonnier, M., Bayer, A., and Madhun, Z., Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling, Am. J. Physiol., 265, E906, 1993.
41. Agishi, Y. and Dingman, J. F., Specific tritiation of oxytocin by catalytic deiodination, Biochem. Biophys. Res. Comm., 18, 92, 1965.
42. Morgat, J. L., Hung, L. T., Cardinaud, R., Fromageot, P., Bockaert, J., Imbert, M., and Morel, F., Peptidic hormone interactions at the molecular level. Preparation of highly labeled [3H] oxytocin, J. Labelled Comp., 6, 270, 1970.
43. Pradelles, P., Morgat, J. L., Fromageot, P., Gamier, M., Bonne, D., Cohen, P., Bockaert, J., and Jard, S., Tritium labeling of (8-lysine)-vasopressin and its purification by affinity chromatography on Sepharosebound neurophysins, FEBS Lett., 26, 189, 1972.
44. Flouret, G., Terada, S.H., Nakahara, T., and Hechter, O., Iodinated neurohypophyseal hormones as potential ligands for receptor binding and intermediates in synthesis of tritiated hormones, Biochemistry, 16, 2119, 1977.
45. Camier, M., Alazard, R., Cohen, P., Pradelles, P., Morgat, J. L., and Fromageot, P., Hormonal interactions at the molecular level: a study of oxytocin and vasopressin binding to bovine neurophysins, Eur. J. Biochem., 32, 207, 1973.
46. 7]OT: a highly selective ligand for central and peripheral OT receptors, Am. J. Physiol., 253, E31, 1988.
47. 3H] 1-Desamino-8-D-Arginine vasopressin as a radioligand for vasopressin V2-receptor in rat kidney, Endocrinol., 122, 1328, 1988.
48. 3H]-SK&F 101926, Mol. Pharmacol., 31, 267, 1987.
49. Manning, M., Bankowski, K., and Sawyer, W. H., Selective agonists and antagonists of vasopressin, In Vasopressin, Principles and Properties, Gash, D. M. and Boer, G. J., Eds., Plenum Press, New York, 1987, 335.
50. Jard, S., Gaillard, R. C., Guillon, G., Marie, J., Schoenenberg, P., Muller, A. F., Manning, M., and Sawyer, W. H., Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis, Mol. Pharmacol., 30, 171, 1986.
51. 5 Tyr(Me)VP in the rat brain, pituitary and kidney, Neurosci. Lett., 80, 121, 1987.
52. Dorsa, D. M., Brot, M. D., Shewey, L. M., Meyers, K. M., Szot, P., and Miller, M. A., Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain, Synapse, 2, 205, 1988.
53. 8 vasopressin receptor with a radiolabeled V1-selective antagonist, J. Recept. Res., 9, 1, 1989.
54. 2 receptor antagonist radioligand, Peptides, 12, 1195, 1991.
55. Serradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, P., Guiraudou, P., Christophe, B., Villanova, G., Nisato, D., Maffrand, J. P., Le Fur, G., Guillon, G., Cantau, B., Barberis, C., Trueba, M., Ala, Y., and Jard, S., Biochemical and pharmacological properties of SR 49059, a new potent, nonpeptide antagonist of rat and human vasopressin V1a receptors, J. Clin. Invest., 92, 224, 1993.
56. Serradeil-Le Gal, C., Raufaste, D., Marty, E., Garcia, C., Maffrand, J. P., and Le Fur, G., Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes, Biochem. Biophys. Res. Comm., 199, 353, 1994.
57. Guillon, G. and Butlen, D., Kinetical and physicochemical properties of V1 and V2 vasopressin receptors: relation to cyclic AMP-dependent and calcium-dependent activation processes, in Hormones and Cell Regulation, Dumont, J. E. and Nunez, J., Eds., 1984, vol. 8, 69.
58. Jard, S., Lombard, C., Seyer, R., Aumelas, A., Manning, M., and Sawyer, W. H., Iodination of vasopressin analogs with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors, Mol. Pharmacol., 32, 369, 1987.
59. 125I]-8-arginine vasopressin binding to human mononuclear phagocytes, J. Clin. Invest., 68, 374, 1981.
60. Moore, M. L., Huffman, W. F., Roberts, G. D., Rottschaefer, S., Sulat, L., Stefankiewicz, J. S., and Stassen, F., Synthesis and characterization of iodinated vasopressin antagonists which retain high affinity for the vasopressin receptor, Biochem. Biophys. Res. Comm., 121, 1984.
61. Manning, M., Olma, A., Klis, W., Kolodziejcyzk, A., Nawrocka, E., Misicka, A., Seto, J., and Sawyer, W. H., Carboxy terminus of vasopressin required for activity but not binding, Nature, 308, 652, 1984.
62. 9]OVT: a selective OT receptor ligand, Eur. J. Pharmacol., 147, 197, 1988.
63. Tribollet, E., Charpak, S., Schmidt, A., Dubois-Dauphin, M., and Dreifuss, J. J., Appearance and transient expression of oxytocin receptors in fetal, infant and peripubertal rat brain studied by autoradiography and electrophysiology, J. Neurosci., 9, 1764, 1989.
64. 9] AVP: iodination and binding characteristics of a vasopressin receptor ligand, FEBS Lett., 229, 251, 1988.
65. 7]AVP: a selective radioligand for V1 vasopressin receptors, J. Receptor Res., 9, 27, 1989.
66. Gerstberger, R. and Fahrenholz, F., Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney, Eur. J. Pharmacol., 167, 105, 1989.
67. Ferris, C., Delville, Y., Grzonka, S., Luber-Narod, J., and Insel, T., An iodinated vasopressin (V1) antagonist blocks flank marking and selectively labels neural binding sites in golden hamster, Physiol. Behavior, 54, 737, 1993.
68. Manning, M., Stoev, S., Kolodziejczyk, A., Klis, W. A., Kruszynski, M., Misicka, A., Olma, A., Wo, N. C., and Sawyer, W. H., Design of potent and selective linear antagonists of the vasopressin (V1-receptor) responses to vasopressin, J. Med. Chem., 33, 3079, 1990.
69. Schmidt, A., Audigier, S., Barberis, C., Jard, S., Manning, M., Kolodziejczyk, A. S., and Sawyer, W. H., A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors, FEBS Lett., 282, 77, 1991.
70. Barberis, C., Balestre, M. N., Jard, S., Tribollet, E., Arsenijevic, Y., Dreifuss, J. J., Bankowski, K., Manning, M., Chan, W. Y., Schlosser, S. S., Holsboer, F., and Elands, J., Characterization of a novel linear radio-iodinated antagonist: an excellent radioligand for vasopressin V1a receptors, Neuroendocrinology, 62, 135, 1995.
71. Ravid, R., Swaab, D. F., Van der Woude, T. P., and Boer, G. J., Immunocytochemically-stained vasopressin binding sites in rat brain. Ventricular application of vasopressin/accurel in the Brattleboro rat, J. Neurol. Sci., 76, 317, 1986.
72. Knigge, K. M., Piekut, D. T., Berlove, D. J., Junig, J. T., and Melrose, P. A., Staining of magnocellular neurons of the supraoptic and paraventricular nuclei with vasopressin anti-idiotype antibody: A potential method for receptor immunocytochemistry, Mol. Brain Res., 2, 69, 1987.
73. Abood, L. G., Xin, L., Michael, G., and Knigge, K. M., Interaction of putative vasopressin receptors in rat brain and bovine pituitary gland with a vasopressin anti-idiotype antibody as revealed by immunoblotting, Peptides, 9, 1407, 1989.
74. 6] AVP(4-9) binding sites, J. Neuroendocrinol., 5, 523, 1993.
75. Trinder, D., Mooser, V., Phillips, P. A., Smith, A. I., Casley, D., and Johnston, C. I., Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranes, Clin. Exp. Pharmacol Physiol., 20, 443, 1993.
76. Takemura, M., Kimura, T., Nomura, S., Makino, Y., Inoue, T., Kikuchi, T., Kubota, Y., Tokugawa, Y., Nobunaga, T., Kamiura, S., Onoue, H., Azuma, C., Saji, F., Kitamura, Y., and Tanizawa, O., Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition, J. Clin. Invest., 93, 2319, 1994.
77. Hirasawa, A., Hashimoto, K., and Tsujimoto, G., Distribution and developmental change of vasopressin V1a and V2 receptor mRNA in rats, Eur. J. Pharmacol., 267, 71, 1994.
78. Ostrowski, N. L., Lolait, S. J., and Young, W. S. III, Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature, Endocrinol., 135, 1511, 1994.
79. Ostrowski, N. L., Lolait, S. J., Bradley, D. J., O'Carroll, A. M., Brownstein, M. J., and Young, W. S. III, Distribution of V1a and V2 receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain, Endocrinol., 131, 533, 1992.
80. Ostrowski, N. L., Young, W. S. III, and Knepper, M. A., Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embyonic, developing, and adult rats, Endocrinol., 133, 1849, 1993.
81. Szot, P., Bale, T. L., and Dorsa, D. M., Distribution of messenger RNA for the vasopressin V1a receptor in the CNS of male and female rats, Mol. Brain Res., 24, 1, 1994.
82. Yoshimura, R., Kiyama, H., Kimura, T., Araki, T., Maeno, H., Tanizawa, O., and Tohyama, M., Localization of oxytocin receptor messenger ribonucleic acid in the rat brain, Endocrinol., 133, 1239, 1993.
83. Manning, M. and Sawyer, W. H., Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin, J. Recept. Res., 13, 195, 1993.
84. Jard, S. and Thibonnier, M., Récepteurs et mécanismes d'action de la vasopressine, in La vasopressine en 1993, Logeais J., Ed., Issy-les-Moulineaux, 1993, 43.
85. Yamamura, Y., Ogawa, H., Chihara, T., Kondo, K., Onogawa, T., Nakamura, S., Mori, T., Tominaga, M., and Yabuuchi, Y., OPC-21268, an orally effective, non-peptide vasopressin V1 receptor antagonist, Science, 252, 572, 1991.
86. Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., Tominaga, M., and Yabuuchi, Y., Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, non-peptide vasopressin V2 receptor antagonist, Br. J. Pharmacol., 105, 787, 1992.
87. Kinter, L. B., Ilson, B. E., Caltabianol, S., Jorkasky, D. K., Murphy, D. J., Solleveld, H. A., Rhodes, G. R., Brooks, D. P., Albrightson-Winslow, C. R., Stote, R. M., and Huffman, W. F., Antidiuretic hormone antagonism in humans: are there predictors? in Vasopressin, Jard, S., and Jamison, R., Eds., John Libbey Eurotext, Paris, 208, 321, 1991.
88. Schwartz, J., Derdowska, I., Sobocinska, M., and Kupryszewski, G., A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary, Endocrinol., 129, 1107, 1991.
89. Antoni, F. A., Novel ligand specificity of pituitary vasopressin receptors in the rat, Neuroendocrinol., 39, 186, 1984.
90. Rivier, C., Rivier, J., Mormede, P., and Vale, W., Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat, Endocrinol., 115, 882, 1984.
91. Bankowski, K., Manning, M., Haldar, J., and Sawyer, W. H., Design and synthesis of potent antagonists of the vasopressor response to arginine vasopressin, J. Med. Chem., 21, 850, 1978.
92. Manning, M., Bankowski, K., Barberis, C., Jard, S., Elands, J., and Chan, W. Y., Novel approach to the design of synthetic radioiodinated linear V1a receptor antagonists of vasopressin, Int. J. Peptide Protein Res., 40, 261, 1992.
93. Melin, P., Oxytocin antagonists and their therapeutic use, Regulatory Peptides, 45, 285, 1993.
94. Pettibone, D. J., Clineschmidt, B. V., Anderson, P. S., Freidinger, R. M., Lundell, G. F., Koupal, L. R., Schwartz, C. D., Williamson, J. M., Goetz, M. A., Hensens, O. D., Liesch, J. M., and Springer, J. P., A structurally unique, potent and selective oxytocin antagonist derived from Streptomyces silvensis, Endocrinol., 125, 217, 1989.
95. Williams, P. D., Anderson, P. S., Ball, R. G., Bock, M. G., Carroll, L. A., Chiu, S. H. L., Clineschmidt, B. V., Culberson, J. C., Erb, J. M., Evans, B. E., Fitzpatrick, S. L., Freidinger, R. M., Kaufman, M. J., Lundell, G. F., Murphy, J. S., Pawluczyk, J. M., Perlow, D. E., Pettibone, D. J., Pitzenberger, S. M., Thompson, K. L., and Veber, D. F., 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl) butyramido)bicyclo[2.2.1]-heptan-1(S)-yl)methylsulfonyl)-4-(2-methylphenyl) piperazine (L-368, 899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor, J. Med. Chem., 37, 565, 1994.
96. Pettibone, D. J., Kishel, M. T., Woyden, C. J., Clineschmidt, B. V., Bock, M. G., Freidinger, R. M., Veber, D. F., and Williams, P. D., Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues, Life Sci., 50, 1953, 1992.
97. Maggi, M., Kassis, S., Malozowski, S., Guardabasso, V., and Rodbard, D., Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles, Proc. Natl. Acad. Sci. U.S.A., 83, 8824, 1986.
98. Lolait, S. J., O'Carroll, A. M., McBride, O. W., Konig, M., Morel, A., and Brownstein, M. J., Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus, Nature, 357, 336, 1992.
99. 2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line, Eur. J. Biochem., 215, 1, 1993.
100. Birnbaumer, M., Seibold, A., Gilbert, S., Ishido, M., Barberis, C., Antaramian, A., Brabet, P., and Rosenthal, W., Molecular cloning of the receptor for human antidiuretic hormone, Nature, 357, 333, 1992.
101. Morel, A., O'Carroll, A., Brownstein, M., and Lolait, S., Molecular cloning and expression of a rat V1a arginine vasopressin receptor, Nature, 356, 523, 1992.
102. Thibonnier, M., Auzan, C., Madhun, Z., Wilkins, P., Berti-Mattera, L., and Clauser, E., Molecular cloning, sequencing and functional expression of a cDNA encoding the human V1a vasopressin receptor, J. Biol. Chem., 269, 3304, 1994.
103. Hirasawa, A., Shibata, K., Kotosa, K., and Tsujimoto, G., Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor, Biochem. Biophys. Res. Comm., 203, 72, 1994.
104. Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., and Kawashima, H., Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor, J. Biol. Chem., 269, 27088, 1994.
105. Kimura, T., Tanizawa, O., Mori, K., Brownstein, M., and Okayama, H., Structure and expression of a human oxytocin receptor, Nature, 356, 526, 1992.
106. Rozen, F., Russo, C., Banville, D., and Zingg, H. H., Structure, characterization, and expression of the rat oxytocin receptor gene, Proc. Natl. Acad. Sci. U.S.A., 92, 200, 1995.
107. Mahlmann, S., Meyerhof, W., Hausmann, H., Heierhorst, I., Schönrock, C., Zwiers, H., Lederis, K., and Richter, D., Structure, function and phylogeny of [Arg8] vasotocin receptors from teleost fish and toad, Proc. Natl. Acad. Sci. U.S.A., 91, 1342, 1994.
108. Jans, D. and Hemmings, B., cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells, FEBS Lett., 281, 267, 1991.
109. Birnbaumer, M., Antaramian, A., Theminen, A., and Gilbert, S., Desensitization of the human V2 vasopressin receptor. Homologous effects in the absence of heterologous desensitization, J. Biol. Chem., 267, 11783, 1992.
110. Gopalakrishnan, V., McNeill, J., Sulakhe, P., and Triggle, C., Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethyl maleimide on agonist and antagonist interactions with the V1 subtype receptor, Endocrinol., 123, 922, 1988.
111. Pavo, I. and Fahrenholz, F., Differential inactivations of vasopressin receptor subtypes in isolated membranes and intact cells by N-ethylmaleimide, FEBS Lett., 272, 205, 1990.
112. Thibonnier, M., Goraya, T., and Berti-Mattera, L., G protein coupling of human platelet V1 vascular vasopressin receptors, Am. J. Physiol., 264, C1336, 1993.
113. Kennedy, M. E. and Limbird, I. E., Mutations of the α2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling, J. Biol. Chem., 268, 8003, 1993.
114. O'Dowd, B., Hnatowich, M., Caron, M., Lefkowitz, R., and Bouvier, M., Palmitoylation of the human β2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled non palmitoylated form of the receptor, J. Biol. Chem., 264, 7564, 1989.
115. Barberis, C., Balestre, M., Mouillac, B., Morel, A., Elands, J., Hoflack, J., Trumpp-Kallmeyer, S., Hibert, M., and Jard, S., Site-directed mutagenesis of V1a vasopressin receptor: identification of aminoacids involved in ligand binding, in Vasopressin, Gross, P., Richter, D., and Robertson, G. L., Eds., John Libbey Eurotext, 1993, 69.
116. Kojro, E., Eich, P., Gimpl, G., and Fahrenholz, F., Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor, Biochemistry, 32, 13537, 1993.
117. Firsov, D., Mandon, B., Morel, A., Merot, J., Le Maout, S., Bellanger, A. C., De Rouffignac, C., Elalouf, J. M., and Buhler, J. M., Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor, Pflügers Arch. Eur. J. Physiol., 429, 79, 1994.
118. Seibold, A., Brabet, P., Rosenthal, W., and Birnbaumer, M., Structure and chromosomal localization of the human antidiuretic hormone receptor gene, Am. J. Hum. Genet., 51, 1078, 1992.
119. Bichet, D., Birnbaumer, M., Lonergan, M., Arthus, M., Rosenthal, W., Goodyer, P., Nivet, H., Benoit, S., Giampietro, P., Simonetti, S., Fish, A., Whitley, C., Jarger, P., Gertner, J., New, M., Dibona, F., Kaplan, B., Robertson, G., Hendy, G., Fujiwara, T., and Morgan, K., Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus, Am. J. Hum. Genet, 55, 278, 1994.
120. Rosenthal, W., Antaramian, A., Gilbert, S., and Birnbaumer, M., Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase, J. Biol. Chem., 268, 13030, 1993.
121. Birnbaumer, M., Gilbert, S., and Rosenthal, W., An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression affinity for ligand and coupling to the Gs/adenylyl cyclase system, Mol. Endocrinol., 8, 886, 1994.
122. Inoue, T., Kimura, T. Azuma, C., Inazawa, J., Takemura, M., Kikuchi, T., Kubota, Y., Ogita, K., and Saji, P., Structural organization of the human oxytocin receptor gene, J. Biol. Chem., 269, 32451, 1994.
123. 3H]-AVP binding sites in particulate preparations of rat brain, Peptides, 4, 335, 1983.
124. Costantini, M. G. and Pearlmutter, A. F., Properties of the specific binding sites for arginine vasopressin in rat hippocampal synaptic membranes, J. Biol. Chem., 259, 11739, 1984.
125. Dorsa, D. M., Petracca, F. M., Baskin, D., and Cornett, L. E., Localization and characterization of vasopressin-binding sites in the amygdala of the rat brain, J. Neurosci., 4, 1764, 1984.
126. 8-vasopressin binding to rat kidney and brain tissue, Peptides, 4, 699, 1983.
127. Cornett, L. E. and Dorsa, D. M., Vasopressin receptor subtypes in dorsal hindbrain and renal medulla, Peptides, 6, 85, 1985.
128. Shewey, L. and Dorsa, D., V1-type vasopressin receptors in rat brain septum: binding characterization and effects on inositol phospholipid metabolism, J. Neurosci., 8, 1671, 1988.
129. Kiraly, M., Audigier, S., Tribollet, E., Barberis, C., Dolivo, M., and Dreifuss, J. J., Biochemical and electrophysiological evidence of functional vasopressin receptors in the rat superior cervical ganglion, Proc. Natl. Acad. Sci. U.S.A., 83, 5335, 1986.
130. Poulin, P., Lederis, K., and Pittman, Q., Subcellular localization and characterization of vasopressin binding sites in the ventral septal area, lateral septum and hippocampus of the rat brain, J. Neurochem., 50, 889, 1988.
131. Jard, S., Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent and cyclic AMP-independent transduction mechanisms, Current Topics Membrane Transport, 18, 255, 1983.
132. Junig, J. T., Abood, L. G., and Skrobala, A. M., Two classes of arginine vasopressin binding sites on rat brain membranes, Neurochem. Res., 10, 1187, 1985.
133. Szot, P., Ferris, C., and Dorsa, D., [3H] arginine-vasopressin binding sites in the CNS of the golden hamster, Neurosci. Lett., 119, 215, 1990.
134. De Kloet, E. R., Voorhuis, T. A. M., Burbach, J. P. H., and De Wied, D., Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4-9, in rat brain, Neurosci. Lett., 56, 7, 1985.
135. Brinton, R. E., Wamsley, J. K., Gehlert, D., Wan, Y. P., and Yamamura, H., Vasopressin metabolite, AVP4-9, binding sites in brain: distribution distinct from that of parent peptide, Life Sci., 38, 443, 1986.
136. Pearlmutter, A. F., Szkrybalo, M., Kim, Y., and Harik, S., Arginine vasopressin receptors in pig cerebral microvessels, cerebral cortex and hippocampus, Neurosci. Lett., 87, 121, 1988.
137. Kretzschmar, R., Landgraf, R., Gjedde, A., and Ennisch, A., Vasopressin binds to microvessels from rat hippocampus, Brain Res., 380, 325, 1986.
138. Katusic, Z.S., Shepherd, J.T., and Vanhoutte, P.M., Vasopressin causes endothelium-dependent relaxations of the canine basilar artery, Circ. Res., 55, 575, 1984.
139. Nakai, M., Contractile effects of perivascularly applied vasopressin on the pial artery of the cat brain, J. Physiol., 387, 441, 1987.
140. 3H] vasopressin-labeled specific binding sites in the canary brain, Brain Res., 457, 148, 1988.
141. Voorhuis, T., Elands, J., and De Kloet, E., Vasotocin target sites in the capsular region surrounding the nucleus robustus archistriatalis of the canary brain, J. Neuroendocrinol., 5, 653, 1990.
142. Di Scala-Guenot, D., Strosser, M., Freund-Mercier, M., and Richard, P., Characterization of oxytocin binding sites in primary rat brain cell cultures, Brain Res., 524, 10, 1990.
143. Di Scala-Guenot, D. and Strosser, M. T., Oxytocin receptors on cultured astroglial cells. Kinetics and pharmacological characterization of oxytocin-binding sites on intact hypothalamic and hippocampic cells from foetal rat brain, Biochem. J., 284, 491, 1992.
144. Di Scala-Guenot, D. and Strosser, M. T., Oxytocin receptors on cultured astroglial cells. Regulation by a guanine-nucleotide binding protein and effect of Mg++, Biochem. J., 284, 499, 1992.
145. Di Scala-Guenot, D., Mouginot, D., and Strosser, M., Increase of intracellular calcium induced by oxytocin in hypothalamic cultured astrocytes, Glia, 11, 269, 1994.
146. Di Scala-Guenot, D. and Strosser, M., Down-regulation of the oxytocin receptor on cultured astroglial cells, Am. J. Physiol., 268, C413, 1995.
147. Insel, T. R., Winslow, J. T., and Witt, D. M., Homologous regulation of brain oxytocin receptors, Endocrinol., 130, 2602, 1992.
148. Burbach, J. P. H. and Lebouffle, J. L. M., Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanism of proteolysis, J. Biol. Chem., 258, 1487, 1983.
149. Burbach, J. P. H., Kovacs, G. L., De Wied, D., Van Nispen, J. W., and Greven, H. M., A major metabolite of arginine-vasopressin in the brain is a highly potent neuropeptide, Science, 221, 1310, 1983.
150. Burbach, J. P. H., Wang, X. C., Ten Haaf, J. A., and De Wied, D., Substances resembling C-terminal vasopressin fragments are present in the brain but not in the pituitary gland, Brain Res., 306, 384, 1984.
151. Burbach, J. P. H., Kovacs, G. L., Wang, X. C., and De Wied, D., Metabolites of arginine-vasopressin and oxytocin are highly potent neuropeptides in the brain, in Biochemical and Clinical Aspects of Neuropeptides: Biosynthesis, Processing and Gene Structure, Koch G. and Richter K., Eds., Academic Press, New York, 1983, 211.
152. De Wied, D., Gaffori, O., Burbach, J. P. H., Kovacs, G. L., and Van Ree, J. M., Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behavior of rats, J. Pharmacol. Exp. Ther., 241, 268, 1987.
153. Du, Y., Wu, J., Jiang, S., and Gu, Y., Characterization of binding sites of a memory-enhancing peptide AVP(4-8) in rat cortical synaptosomal membranes, Peptides, 15, 1273, 1994.
154. Orloff, J. and Handler, J., The role of adenosine 3′,5′-phosphate in the action of antidiuretic hormone, Am. J. Med., 42, 757, 1967.
155. Michell, R. H., Kirk, C. J., and Billah, M. M., Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin, Biochem. Soc. Trans., 7, 861, 1979.
156. Sternweis, P.C. and Smrcka, A.V., Regulation of phospholipase C by G proteins, TIBS, 17, 502, 1992.
157. Offermanns, S., Heiler, B., Spicher, K., and Schultz, G., Gq and G11 are concurrently activated by bombesin and vasopressin in Swiss 3T3 cells, FEBS Lett., 349, 201, 1994.
158. Thibonnier, M., Bayer, A. L., Simonson, M. S., and Kester, M., Multiple signaling pathways of V1-vascular AVP receptors of A7r5 cells, Endocrinol., 129, 2845, 1991.
159. Welsh, C., Scheichel, K., Cao, H., and Chabbott, H., Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells, Lipids, 25, 675, 1990.
160. Berk, B., Brock, T., Gimbrone, M., and Alexander, R., Early agonist-mediated ionic events in cultured vascular smooth muscle cells, J. Biol. Chem., 262, 5065, 1987.
161. Briley, E., Lolait, S., Axelrod, J., and Felder, C., The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C and phospholipase D through activation of receptor-operated calcium chan4 nels, Neuropeptides, 27, 63, 1994.
162. Raymond, V., Leung, P. C. K., Veilleux, R., and Labrie, F., Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells, FEBS Lett., 182, 196, 1985.
163. Mirronneau, J., Effects of oxytocin on ionic currents underlying rhythm activity and contraction in uterine smooth muscle, Pflüger's Arch., 363, 113, 1976.
164. Marc, S., Leiber, D., and Harbon, S., Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea pig myometrium, FEBS Lett., 201, 9, 1986.
165. Flint, A. P. F., Leat, W. M. F., Sheldrick, E. L., and Stewart, H. J., Stimulation of phosphoinositide hydrolysis by oxytocin and the mechanism by which oxytocin controls prostaglandin synthesis in the ovine endometrium, Biochem. J., 237, 797, 1986.
166. Schrey, M. P., Read, A. M., and Steer, P. J., Oxytocin and vasopressin stimulate inositol phosphate production in human gestational myometrium and decidua cells, Biosci. Rep., 6, 613, 1986.
167. Zhao, X. and Gorewit, R. C., Oxytocin receptors in bovine mammary tissue, J. Receptor Res., 7, 729, 1987.
168. Phaneuf, S., Europe-Finner, G. N., Vanney, M., MacKenzie, I. Z., Watson, S. P., and Lopez Bernai, A., Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins, J. Endocrinol., 136, 497, 1993.
169. Moore, J., Dubyak, G., Moore, R., and Kooy, D., Oxytocin activates the inositol-phospholipid-protein kinase C system and stimulates prostaglandin production in human amnion cells, Endocrinol., 123, 1771, 1988.
170. Soloff, M. S. and Sweet, P., Oxytocin inhibition of (Ca2++ Mg2+)-ATPase activity in rat myometrial plasma membranes, J. Biol. Chem., 257, 10687, 1982.
171. Allgert, G. and Exton, J., Insulin and oxytocin effects on phosphoinositide metabolism in adipocytes, J. Biol. Chem., 263, 3600, 1988.
172. Bonne, D. and Cohen, P., Characterization of oxytocin receptors on isolated rat fat cells, Eur. J. Biochem., 56, 295, 1975.
173. Stephens, L. R. and Logan, S. D., Arginine-vasopressin stimulates inositol phospholipid metabolism in rat hippocampus, J. Neurochem., 46, 649, 1986.
174. Moratalla, R., Vallejo, M., and Lightman, S., Vasopressin stimulates inositol phospholipid metabolism in rat medulla oblongata in vivo, Brain Res., 450, 398, 1988.
175. Lebrun, C., Gruber, M., Meister, M., and Unger, T., Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat system, Brain Res., 531, 167, 1990.
176. Poulin, P. and Pittman, Q., Arginine vasopressin-induced sensitization in brain facilitated inositol phosphate production without changes in receptor number, J. Neuroendocrinol., 5, 23, 1993.
177. Kanda, F. and Arieff, A., Vasopressin inhibits calcium-coupled sodium efflux system in rat brain, Am. J. Physiol., 266, R1169, 1994.
178. Bone, E. A., Fretten, P., Palmer, S., Kirk, C. J., and Michell, R. H., Rapid accumulation of inositol phosphates in isolated rat superior cervical sympathetic ganglia exposed to V1-vasopressin and muscarinic cholinergic stimuli, Biochem. J., 221, 803, 1984.
179. Horwitz, J., Anderson, C. H., and Perlman, R. L., Comparison of the effects of muscarine and vasopressin on inositol phospholipid metabolism in the superior cervical ganglion of the rat, J. Pharmacol. Exp. Ther., 237, 312, 1986.
180. Horn, A. and Lightman, S., Vasopressin-stimulated turnover of phosphatidylinositol on the decentralized superior cervical ganglion of the rat, Brain Res., 455, 18, 1988.
181. Brinton, R. E. and McEwen, B., Vasopressin neuromodulation in the hippocampus, J. Neurosci. 9, 752, 1989.
182. Newman, M., Vasopressin inhibits cyclic AMP accumulation and adenylate cyclase activity in cerebral preparations, FEBS Lett., 181, 203, 1985.
183. Church, A., Vasopressin potentiates the stimulation of cyclic AMP accumulation by norepinephrine, Peptides, 4, 261, 1983.
184. Courtney, N. and Raskind, M., Vasopressin affects adenylate cyclase activity in rat brain: a possible neuromodulator, Life Sci., 32, 591, 1983.
185. Petit, P., Barberis, C., and Jard, S., Vasopressin potentiates the noradrenaline-induced accumulation of cyclic AMP in the rat superior cervical ganglion, Brain Res., 440, 299, 1988.
186. Giguere, V. and Labrie, F., Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin releasing factor in rat anterior pituitary cells in culture, Endocrinol., 111, 1752, 1982.
187. Jard, S., Barberis, C., Guillon, G., Petit, P., and Gaillard, R., Potentiation by vasopressin of CRF- and β-adrenergic agonist-induced responses: studies on the adenohypophysis and superior cervical ganglion, in Vasopressin: Cellular and Integrative Functions, Cowley, A. W., Liard, J. F., and Ausiello, D. A., Eds., Raven Press, New York, 1988, 11.
188. Brinton, R. D. and Brownson, E. A., Vasopressin-induction of cyclic AMP in cultured hippocampal neurons, Develop. Brain Res., 71, 101, 1993.
189. Elands, J., Neurohypophyseal hormone receptors, Thesis, University of Utrecht, 1989.
190. De Kloet, E. R., Rotteveel, F., Voorhuis, T. A. M., and Terlou, M., Topography of binding sites for neurohypophyseal hormones in rat brain, Eur. J. Pharmacol., 110, 113, 1985.
191. Freund-Mercier, M. J., Dietl, M. M., Stoeckel, M. E., Palacios, J. M., and Richard, P., Quantitative autoradiographic mapping of neurohypophysial hormone binding sites in the rat forebrain and pituitary gland. I. Characterization of different types of binding sites and their distribution in the Long-Evans strain, Neurosci., 26, 261, 1988.
192. Freund-Mercier, M. J., Dietl, M. M., Stoeckel, M. E., Palacios, J. M., and Richard, P., Quantitative autoradiographic mapping of neurohypophysial hormone binding sites in the rat forebrain and pituitary gland. II. Comparative study of the Long-Evans and Brattleboro strains, Neurosci., 26, 273, 1988.
193. Elands, J., Beetsma, A., Barberis, C., and De Kloet, E. R., Topography of the oxytocin receptor system in rat brain: an autoradiographical study with a selective radioiodinated oxytocin antagonist, J. Clin. Neuroanatomy, 1, 293, 1988
194. Kremarik, P., Freund-Mercier, M., and Stoeckel, M. E., Histoautoradiographic detection of oxytocin- and vasopressin-binding sites in the telencephalon of the rat, J. Comp. Neurol. 333, 343, 1993.
195. Kremarik, A., Freund-Mercier, M. J., and Stoeckel, M. E., Oxytocin- and vasopressing-binding sites in the hypothalamus of the rat: histoautoradiographic detection, Brain Res. Bull., 36, 195, 1995.
196. Mühlethaler, M., Sawyer, W. H., Manning, M. M., and Dreifuss, J. J., Characterization of a uterine-type oxytocin receptor in the rat hippocampus, Proc. Natl. Acad. Sci. U.S.A., 80, 6713, 1983.
197. Rogers, R. C. and Herman, C. E., Hypothalamic paraventricular nucleus stimulation-induced gastric acid secretion and bradycardia suppressed by oxytocin antagonist, Peptides, 7, 695, 1986.
198. Raggenbass, M., Dubois-Dauphin, M., Charpak, S., and Dreifuss, J. J., Neurons in the dorsal motor nucleus of the vagus nerve are excited by oxytocin in the rat but not in the guinea-pig, Proc. Natl. Acad. Sci. U.S.A., 84, 3926, 1987.
199. Tribollet, E., Barberis, C., Jard, S., Dubois-Dauphin, M., and Dreifuss, J. J., Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography, Brain Res., 442, 105, 1988.
200. 3H] vasopressin binding detected by autoradiography in the hypothalamo-neurohypophyseal system, J. Neuroendocrinol., 3, 285, 1991.
201. Freund-Mercier, M. J., Stoeckel, M. E., and Klein, M. J., Oxytocin receptors on oxytocin neurons : histoautoradiographic detection in the lactating rat, J. Physiol., 480, 155, 1994.
202. Reiter, M., Kremarik, P., Freund-Mercier, M., Stoeckel, M., Desaulles, E., and Feltz, P., Localization of oxytocin binding sites in the thoracic and upper lumbar spinal cord of the adult and postnatal rat: a histoautoradiographic study, Eur. J. Neurosci., 6, 1994.
203. Faraci, F. M., Mayhan, W. G., Farell, W. J., and Heistad, D. D., Humoral regulation of blood flow to choroid plexus: role of arginine vasopressin, Circ. Res., 55, 575, 1988.
204. Tsugane, S., Suzuki, Y., Takayasu, M., Shibuya, M., and Sugita, K., Effects of vasopressin on regional cerebral blood flow in dogs, J. Autonomic Nervous System, 49, S133, 1994.
205. Brinton, R. E., Wamsley, J. K., Gehlert, D., Wan, Y. P., and Yamamura, H., Vasopressin metabolite peptide, AVP(4-9) binding sites in rat kidney: distribution distinct from vasopressin binding sites, Eur. J. Pharmacol., 108, 321, 1985.
206. Freund-Mercier, M. J. and Richard, P., Electrophysiological evidence for a facilitating control of oxytocin neurons by oxytocin during suckling in the rat, J. Physiol., 252, 447, 1984.
207. Theodosis, D. T., Montagnese, C., Rodriguez, F., Vincent, J., and Poulain, D. A., Oxytocin induces morphological plasticity in the adult hypothalamoneurohypophysial system, Nature, 322, 738, 1986.
208. Yamashita, H., Okuya, S., Inenaga, K., Kasai, M., Uesugi, S., Kannan, H., and Kaneko, T., Oxytocin predominantly excites putative oxytocin neurons in the rat supraoptic nucleus in vitro, Brain Res, 416, 364, 1987.
209. Kuriyama, K., Nakashima, T., Kawarabayashi, T., and Kiyohara, T., Oxytocin inhibits nonphasically firing supraoptic and paraventricular neurons in the virgin female rat. Brain Res. Bull., 31, 681, 1993.
210. 2+ concentration of isolated rat supraoptic cells in response to oxytocin, J. Physiol. 478, 275, 1994.
211. Young, W. S. III., Kovacs, K., and Lolait, S. J., The diurnal rhythm in vasopressin V1a receptor expression in the suprachiasmatic nucleus is not dependent on vasopressin, Endocrinol., 133, 585, 1993.
212. Raggenbass, M., Dubois-Dauphin, M., Tribollet, E., and Dreifuss, J. J., Direct excitatory action of vasopressin in the lateral septum of the rat brain, Brain Res., 459, 60, 1988.
213. Ishizawa, H., Tabakoff, B., Mefford, I., and Hoffman, P., Reduction of arginine vasopressin binding sites in mouse lateral septum by treatment with 6-hydroxydopamine, Brain Res., 507, 189, 1990.
214. Phillips, P., Widdop, R., Chai, S., Kelly, J., Mooser, V., Trinder, D., and Jonhston, C., Reduced V1 vasopressin binding in the rat nucleus solitarii after nodose ganglionectomy, Clin. Exp. Pharmacol. Physiol., 17, 321, 1990.
215. Van Zwieten, E. J., Ravid, R., Swaab, D. F., and Van deWoude, T. J., Immunocytochemically stained vasopressin binding sites on blood vessels in the rat brain, Brain Res., 474, 369, 1988.
216. Jojard, I., Joo, F., Siklos, L., and Laszlo, F. A., Immunohistochemical evidence for innervation of brain microvessels by vasopressin-immunoreactive neurons in the rat, Neurosci. Lett., 51, 259, 1984.
217. Suzuki, Y., Satoh, S., Oyama, H., Takayasu, M., Shibuya, M., and Sugita, K., Vasopressin mediated vasodilation of cerebral arteries, J. Autonomic Nervous System, 49, S129, 1994.
218. Hösli, E. and Hösli, L., Autoradiographic localization of binding sites for arginine vasopressin and atrial natriuretic peptide on astrocytes and neurons of cultured rat central nervous system, Neurosci., 51, 159, 1992.
219. 3H] thymidine incorporation, Neurochem. Int., 13, 393, 1988.
220. Hösli, L., Hösli, E., Lefkovits, M., and Wagner, S., Electrophysiological evidence for the existence of receptors for endothelin and vasopressin on cultures astrocytes of rat spinal cord and brainstem, Neurosci. Lett., 131, 193, 1991.
221. Hatton, G. I., Bicknell, R. J., Hoyland, J., Bunting, R., and Mason, W. T., Arginine vasopressin mobilizes intracellular calcium v1a V1 receptor activation in astrocytes (pituicytes) cultured from adult rat neural lobes, Brain Res., 588, 75, 1992.
222. ++ in sympathetic ganglia, Neurochem. Int., 215, D5, 1992.
223. Tribollet, E., Arsenijevic, Y., Marguerat, A., Dreifuss, J. J., Bertrand, D., and Maury, K., Vasopressin receptors are localized on glial cells in the superior cervical sympathetic ganglion, Experientia, 49, A67, 1993.
224. Raggenbass, M., Tribollet, E., Dubois-Dauphin, M., and Dreifuss, J. J., Vasopressin receptors of the vasopressor (V1) type in the nucleus of the solitary tract of the rat mediate direct neuronal excitation, J. Neurosci., 9, 3929, 1989.
225. Mühlethaler, M., Charpak, S., and Dreifuss, J. J., Contrasting effects of neurohypophysial peptides on pyramidal and non-pyramidal neurons in the rat hippocampus, Brain Res., 308, 97, 1984.
226. Raggenbass, M., Tribollet, E., Dubois-Dauphin, M., and Dreifuss, J. J., Correlation between oxytocin neuronal sensitivity and oxytocin receptor binding: an electrophysiological and autoradiographical study, comparing rat and guinea pig hippocampus, Proc. Natl. Acad. Sci. U.S.A., 86, 750, 1989.
227. Charpak, S., Armstrong, W. E., and Mühlethaler, M., Stimulatory action of oxytocin on neurons of the dorsal motor nucleus of the vagus nerve, Brain Res., 300, 83, 1984.
228. Raggenbass, M. and Dreifuss, J. J., Mechanism of action of oxytocin in rat vagal neurons: induction of a sustained sodium-dependent current, J. Physiol., 457, 131, 1992.
229. Raggenbass, M., Goumaz, M., Sermasi, E., Tribollet, E., and Dreifuss, J. J., Vasopressin generates a persistent voltage dependent sodium current in a mammalian motoneurone, J. Neurosci., 11, 1609, 1991.
230. Widmer, H., Dreifuss, J. J., and Raggenbass, M., N-methyl-D-aspartate and vasopressin activate distinct voltage-dependent inward currents in facial motoneurons, Brain Res., 593, 215, 1992.
231. Alberi, S., Dubois-Dauphin, M., Dreifuss, J. J., and Raggenbass, M., Modulation by divalent cations of the current generated by vasopressin in facial motoneurons, Brain Res., 624, 326, 1993.
232. Dreifuss, J. J., Alberi, S., Arsenijevic, Y., and Raggenbass, M., Vasopressin depolarizes a central neuron by increasing its membrane permeability to small monovalent cations, in Vasopressin, Gross, P., Richter, D., and Robertson, G. L., Eds., John Libbey Eurotext, Paris, 185, 1993.
233. Dreifuss, J. J. and Raggenbass, M., Oxytocin-responsive cells in the mammalian nervous system, Regulatory Peptides, 45, 109, 1993.
234. Boer, G. J., Vasopressin and oxytocin receptors and the developing brain, in Receptors in the Developing Nervous System, vol. 1: Growth Factors and Hormones, Zagon, I. S. and McLaughlin, P. J., Eds., Chapman and Hall, London, 225, 1993.
235. Tribollet, E., Goumaz, M., Raggenbass, M., Dubois-Dauphin, M., and Dreifuss, J. J., Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study, Develop. Brain Res., 58, 13, 1991.
236. Shapiro, L. E. and Insel, T. R., Ontogeny of oxytocin receptors in rat forebrain: a quantitative study, Synapse, 4, 259, 1989.
237. Yoshimura, R., Kimura, T., and Kiyama, H., Differential expression of oxytocin receptor mRNA in developing rat brain, Neurosci. Res., Suppl. 19, S265, 1994.
238. De Kloet, E. R., Voorhuis, D. A. M., Boschma, Y., and Elands, J., Estradiol modulates density of putative "oxytocin receptors" in discrete rat brain regions, Neuroendocrinol., 44, 415, 1986.
239. Tribollet, E., Audigier, S., Dubois-Dauphin, M., and Dreifuss, J. J., Gonadal steroids regulate oxytocin receptors but not vasopressin receptors in the brain of male and female rats. An autoradiographical study, Brain Res., 511, 129, 1990.
240. Johnson, A. E., Coirini, H., Ball, G. F., and McEwen, B. S., Anatomical localization of the effects of 17-β-estradiol on oxytocin receptor binding in the ventromedial hypothalamic nucleus, Endocrinol., 124, 207, 1989.
241. Johnson, A. E., Ball, G. F., Coirini, H., Harbaugh, C. R., McEwen, B. S., and Insel, T. R., Time course of the estradiol-dependent induction of oxytocin receptor binding in the ventromedial hypothalamic nucleus of the rat, Endocrinol., 125, 1414, 1989.
242. Coirini, H., Johnson, A. E., and McEwen, B. S., Estradiol modulation of oxytocin binding in the ventromedial hypothalamic nucleus of male and female rats, Neuroendocrinol., 50, 193, 1989.
243. Johnson, A. E., Coirini, H., McEwen, B. S., and Insel, T. R., Testosterone modulates oxytocin binding in the hypothalamus of castrated male rats, Neuroendocrinol., 50, 199, 1989.
244. Johnson, A. E., Coirini, H., Insel, T. R., and McEwen, B. S., The regulation of oxytocin receptor binding in the ventromedial hypothalamic nucleus by testosterone and its metabolites, Endocrinol., 128, 891, 1991.
245. Caldwell, J. D., Walker, C. H., Pedersen, C. A., Barakat, A. S., and Mason, G. A., Estrogen increases affinity of oxytocin receptors in the medial preoptic area-anterior hypothalamus, Peptides, 15, 1079, 1994.
246. Patchev, V. K., Schlosser, S. F., Hassan, A. H. S., and Almeida, O. F. X., Oxytocin binding sites in rat limbic and hypothalamic structures: site-specific modulation by adrenal and gonadal steroids, Neurosci., 57, 537, 1993.
247. Coirini, H., Johnson, A. E., Schumacher, M., and McEwen, B. S., Sex differences in the regulation of ytocin receptors by ovarian steroids in the ventromedial hypothalamus of the rat, Neuroendocrinol., 55, 269, 1992.
248. Schumacher, M., Coirini, H., Frankfurt, M., and McEwen, B. S., Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors, Science, 250, 691, 1990.
249. Coirini, H., Schumacher, M., Flanagan, L. M., and McEwen, B. S., Transport of estrogen-induced oxytocin receptors in the ventromedial hypothalamus, J. Neurosci., 11, 3317, 1991.
250. Schumacher, M., Coirini, H., Johnson, A. E., Flanagan, L. M., Frankfurt, M., Pfaff, D. W., and McEwen, B. S., The oxytocin receptor: a target for steroid hormones, Regul. Peptides, 45, 115, 1993.
251. Schumacher, M., Coirini, H., Frankfurt, M., and McEwen, B. S., Localized actions of progesterone in hypothalamus involve oxytocin, Proc. Natl. Acad. Sci. U.S.A., 86, 6798, 1989.
252. Gao, X., Phillips, P., Oldfield, B., Trinder, D., Risvanis, J., Stephenson, J., and Johnston, C., Androgen manipulation and vasopressin binding in the rat brain and peripheral organs, Eur. J. Endocrinol., 130, 291, 1994.
253. Saito, R., Ishiharada, N., Ban, Y., Honda, K., Takano, Y., and Kamiya, H., Vasopressin V1 receptor in rat hippocampus is regulated by adrenocortical functions, Brain Res., 646, 170, 1994.
254. Liberzon, I., Chalmers, D. T., Mansour, A., Lopez, J. F., Watson, S. J., and Young, E. A., Glucocorticoid regulation of hippocampal oxytocin receptor binding, Brain Res., 650, 317, 1994.
255. Tribollet, E., Barberis, C., Dubois-Dauphin, M., and Dreifuss, J. J., Localization and pharmacological characterization of binding sites for vasopressin and oxytocin in the brain of the guinea pig, Brain Res., 589, 15, 1992.
256. Dubois-Dauphin, M., Pevet, P., Tribollet, E. and Dreifuss, J. J., Vasopressin in the brain of the golden hamster: the distribution of vasopressin binding sites and of immunoreactivity to the vasopressin-related glycopeptide, J. Comp. Neurol., 300, 535, 1990.
257. Dubois-Dauphin, M., Theler, M., Zaganidis, N., Dominik, W., Tribollet, E., Pevet, P., Charpak, G., and Dreifuss, J. J., Expression of vasopressin receptors in hamster hypothalamus is sexually dimorphic and dependent upon photoperiod, Proc. Natl. Acad. Sci. U.S.A., 88, 11163, 1991.
258. Dubois-Dauphin, M., Pevet, P., Barberis, C., Tribollet, E., and Dreifuss, J. J., Localization of binding sites for oxytocin in the brain of the golden hamster, NeuroReport, 3, 797, 1992.
259. Levy, F., Dreifuss, J. J., Dubois-Dauphin, M., Berti, M., Barberis, C., and Tribollet, E., Autoradiographic detection of vasopressin binding sites but not of oxytocin binding sites in the sheep olfactory bulb, Brain Res., 595, 154, 1992.
260. Insel, T. R. and Shapiro, L. E., Oxytocin receptor distribution reflects social organization in monogaus and polygamous voles, Proc. Natl. Acad. Sci. U.S.A., 81, 2006, 1992.
261. Insel, T. R., Wang, Z. X., and Ferris, C. F., Patterns of brain vasopressin receptors distribution associated with social organization in microtine rodents, J. Neurosci., 14, 5381, 1994.
262. Loup, F., Tribollet, E., Dubois-Dauphin, M., Pizzolato, G., and Dreifuss, J. J., Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study, Brain Res., 500, 223, 1989.
263. Loup, F., Tribollet, E., Dubois-Dauphin, M., and Dreifuss, J. J., Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study, Brain Res., 555, 220, 1991.
264. Tribollet, E., Li, Z., Inenaga, K., Yamashita, H., Raggenbass, M., Dubois-Dauphin, M., and Dreifuss, J. J., Neural effects and binding sites for oxytocin in the ventromedial hypothalamus of the guinea pig after castration, Brain Res., 588, 346, 1992.
265. Delville, Y. and Ferris, C. F., Sexually dimorphic and testosterone-dependent vasopressin binding in the area of the ventromedial nucleus of the hypothalamus in hamsters, Soc. Neurosci. Abstract., 17, 1417, 1991.
266. Johnson, A. E., Barberis, C., and Albers, H. E., Castration reduces vasopressin receptor binding in the hamster hypothalamus, Brain Res., 674, 153, 1995.
267. De Kloet, E. R., Elands, J., and Voorhuis, D. A. M., Implication of central neurohypophyseal hormone receptor-mediated action in the timing of reproductive events: evidence from novel observations on the effect of a vasotocin analogue on singing behavior of the canary, Regul. Peptides, 45, 85, 1993.
268. Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., and Insel, T. R., A role for central vasopressin in pair bonding in monogamous prairie voles, Nature, 365, 545, 1993.
269. Jansen, J. K. S. and Fladby, T., The perinatal reorganization of the innervation of skeletal muscle in mammals, Prog. Neurobiol., 34, 39, 1990.
270. Tribollet, E., Arsenijevic, Y., Barberis, C., Marguerat, A., and Dreifuss, J. J., Axotomy induces the expression of vasopressin receptors in cranial and spinal motor nuclei, Proc. Natl. Acad. Sci. U.S.A., 91, 9636, 1994.
271. Aldskogius, H. and Svensson, M., Neuronal and glial cell responses to axon injury, in Advances in Structural Biology, vol. 2, JAI Press Inc., Greenwich, CT, 1993, 191.
272. Carter, D. A., Chooi, K. F., and Murphy, D., Neurohypophyseal peptides as regulators of growth and development, J. Mol. Neurosci. 4, 11, 1993.
273. Brinton, R. E. and Gruener, R., Vasopressin promotes neurite growth in cultured embryonic neurons, Synapse, 1, 329, 1987.
274. Clos, G. J. and Gabrion, J., A thyroid hormone-vasopressin interaction promotes survival and maturation of hippocampal neurons dissociated postnatally, Neurochem. Res., 14, 919, 1989.
275. Boer, G. J., Vasopressin and brain development: studies using the Brattleboro rat, Peptides, 6, 49, 1985.
276. 3H) -vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation, J. Recept. Res. 1, 137, 1980.
277. Gaillard, R. C., Schoenenberg, P., Favrod-Coune, C.A., Muller, A.F., Marie, J., Bockaert, J., and Jard, S., Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor, Proc. Natl. Acad. Sci. U.S.A., 81, 2907, 1984.
278. Rajerison, R., Marchetti, J., Roy, C., Bockaert, J., and Jard, S., The vasopressin-sensitive adenylate cyclase of the rat kidney; effects of adrenalectomy and corticosteroids on hormonal receptor-enzyme coupling, J. Biol. Chem., 249, 6390, 1974.
279. Lutz-Bucher, B. and Koch, B., Characterization of specific vasopressin receptors for vasopressin in the pituitary gland, Biochem. Biophys. Res. Comm., 115, 492, 1983.
280. Soloff, M. S. and Swartz, T. L., Characterization of a proposed oxytocin receptor in the uterus of the rat and sow, J. Biol. Chem., 248, 6471, 1973.
281. 2 vasopressin isoreceptors, J. Biol. Chem., 267, 18453, 1992.
282. Butlen, D., Guillon, G., Rajerison, R. M., Jard, S., Sawyer, W. H., and Manning, M., Structural equirements for activation of vasopressin-sensitive adenylate cyclase, hormone-binding and antidiuretic actions: effects of highly potent analogues and competitive inhibitors, Mol. Pharmacol., 14, 1006, 1978.
283. Stassen, F. L., Heckman, G. D., Schmidt, D., Stefankiewiecz, J., Sulat, L., Huffman, F., Moore, M., and Kinter, L. B., Actions of vasopressin antagonists: molecular mechanisms, in Vasopressin, Schrier, R. W., Ed., Raven Press, New York, 1985, 145.
284. 1b type, Endocrinol., 135, 2058, 1994.
285. Rami, A., Barberis, C., and Clos, J., Effects of hypothyroidism on high-affinity vasopressin binding sites in developing hippocampal synaptosomes, Synapse, 3, 200, 1989.
286. Johnson, A. E., Audigier, S., Rossi, F., Jard, S., Tribollet, E., and Barberis, C., Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist, Brain Res., 622, 9, 1993.
287. 1 receptor antagonist, Neurosci., 27, 749, 1988.